Total (n=1,240) Prevalence of Lipoatrophy
Overall (n=1240) Men (n=628) Women (n=612)
Gender        
 Men 628 (50.6) 338 (53.8) - -
 Women 612 (49.4) 322 (52.6) - -
P value   0.7    
Age (years)        
 18-34 471 (38.0) 240 (51.0) 98 (40.8) 142 (59.2)
 35-49 591 (47.7) 329 (55.7) 191 (58.0) 138 (42.0)
 50-78 178 (14.3) 91 (51.1) 49 (53.8) 42 (46.2)
P value   0.3 0.2 0.4
Skin color        
 White 692 (55.8) 329 (47.5) 178 (54.1) 151 (45.9)
 Non-white 548 (44.2) 331 (60.4) 160 (48.3) 171 (51.7)
P value   <0.001 <0.001 0.033
Years at school        
 <12 1,097 (88.5) 606 (55.2) 305 (50.3) 301 (49.7)
 ≥ 12 143 (11.5) 54 (37.8) 33 (61.1) 21 (38.9)
P value   <0.001 <0.001 0.3
Smoking (pack-years)        
 Never-smoker 422 (34.0) 202 (47.9) 86 (42.6) 116 (57.4)
 <20 498 (40.2) 265 (53.2) 128 (48.3) 137 (51.7)
 ≥ 20 320 (25.8) 193 (60.3) 124 (64.2) 69 (35.8)
P value   0.003 0.04 0.10
Physical activity        
 Active 716 (57.7) 397 (55.4) 188 (47.4) 209 (52.6)
 Inactive or sedentary 524 (42.3) 263 (50.2) 150 (57.0) 113 (43.0)
P value   0.07 0.3 0.09
Binge drinking (n=1,226)
 Yes 211 (17.0) 101 (47.9) 71 (70.3) 30 (29.7)
 No 1,029 (83.0) 559 (54.3) 267 (47.8) 292 (52.2)
P value   0.4 0.2 0.17
Body mass index (kg/m2)
 <25 708 (57.1) 445 (62.9) 252 (56.6) 193 (43.4)
 25–29.9 380 (30.6) 152 (40.0) 74 (48.7) 78 (51.3)
 ≥ 30 152 (12.3) 63 (41.4) 12 (19.0) 51 (81.0)
P value   <0.001 <0.001 0.003
Years since HIV diagnosis
 <3 485 (39.1) 234 (48.2) 113 (48.3) 121 (51.7)
 3-5 350 (28.3) 174 (49.7) 88 (50.6) 86 (49.4)
 ≥ 6 404 (32.6) 252 (62.4) 137 (54.4) 115 (45.6)
P value   <0.001 0.002 0.02
Currently on HAART        
 Yes 815 (65.7) 474 (58.2) 248 (52.3) 226 (47.7)
 No 425 (34.3) 186 (43.8) 90 (48.4) 96 (51.6)
P value   <0.001 <0.001 0.002
CD4 count (cel/mm3) (n=1,227)
 <350 476 (38.8) 265 (55.7) 148 (55.8) 117 (44.2)
 ≥ 350 751 (61.2) 387 (51.5) 185 (47.8) 202 (52.2)
P value   0.16 0.04 0.9
HIV-RNA viral load (n=1,221)
 Undetectable 713 (58.4) 279 (39.1) 151 (54.1) 128 (45.9)
 Detectable 508 (41.6) 369 (72.6) 181 (49.1) 188 (50.9)
P value   0.3 0.3 0.7
Total cholesterol (mg/dL) (n=1,226)
 <200 854 (69.7) 465 (54.4) 242 (52.0) 223 (48.0)
 ≥ 200 372 (30.3) 186 (50.0) 89 (47.8) 97 (52.2)
P value   0.04 0.13 0.15
HDL (mg/dL) (n=1,226)
 <35 152 (12.4) 81 (53.3) 58 (71.6) 23 (28.4)
 ≥ 35 1,074 (87.6) (86.7) 570 (53.1) 273 (47.9) 297 (52.1)
P value   0.9 0.7 0.6
LDL (mg/dL) (n=1,225)
 <130 966 (78.9) 528 (54.7) 280 (53.0) 248 (47.0)
 ≥ 130 259 (21.1) 122 (47.1) 50 (41.0) 72 (59.0)
P value   0.03 0.19 0.09
Triglycerides (mg/dL) (n=1,227)
 <150 787 (64.1) 419 (53.2) 203 (48.4) 216 (51.6)
 ≥150 440 (35.9) 232 (52.7) 128 (55.2) 104 (44.8)
P value   0.9 0.10 0.15
Fasting glucose (mg/dL) (n=1,226)
 <126 1,185 (96.7) 629 (53.1) 316 (50.2) 313 (49.8)
 ≥126 41 (3.3) 22 (53.7) 15 (68.2) 7 (31.8)
P value   0.9 0.5 0.5
Percentages for the column of total add 100%; while for prevalence rates, the
100% is in the lines
Table 2: Characteristics of HIV-infected participants and prevalence of lipoatrophy.